📰 Contract Testing News
Page 3 - Contract Testing News Today
Fast, Ad-Free News Updates
Stay updated with breaking news from Contract Testing. Real-time updates on events, politics, business and more.
June 1, 2022
The Digital Lab is Here When modern LIMS software overtook traditional paper-based record-keeping in the lab, operations in every industry improved. Click to read more...
April 28, 2022
/PRNewswire/ -- WuXi Advanced Therapies (WuXi ATU), a wholly owned subsidiary of WuXi AppTec, and A*STARs Bioprocessing Technology Institute (BTI), announced...
April 28, 2022
/PRNewswire/ -- WuXi Advanced Therapies (WuXi ATU), a wholly owned subsidiary of WuXi AppTec, and A*STARs Bioprocessing Technology Institute (BTI), announced...
April 25, 2022
/PRNewswire/ -- WuXi AppTec (stock code: 603259.SH / 2359.HK), a global company that provides a broad portfolio of R&D and manufacturing services that enable...
March 23, 2022
/PRNewswire/ -- WuXi AppTec (stock code: 603259.SH / 2359.HK), a global company that provides a broad portfolio of R&D and manufacturing services that enable...
March 8, 2022
/PRNewswire/ -- WuXi Advanced Therapies (WuXi ATU), a wholly owned subsidiary of WuXi AppTec, today announced the launch of Tetracycline-Enabled Self-Silencing...
March 8, 2022
PHILADELPHIA, March 7, 2022 /PRNewswire/ -- WuXi Advanced Therapies (WuXi ATU), a wholly owned subsidiary of WuXi AppTec, today announced the laun...
March 8, 2022
/PRNewswire/ -- WuXi Advanced Therapies (WuXi ATU), a wholly owned subsidiary of WuXi AppTec, today announced the launch of Tetracycline-Enabled Self-Silencing...
March 8, 2022
Press release content from PR Newswire. The AP news staff was not involved in its creation.
March 8, 2022
TESSA™ technology provides a scalable process for manufacturing gene therapies, accelerating the production of large quantities of therapeutic DNA required to treat patients in need.